Literature DB >> 18421199

Rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis successfully treated with polymyxin B-immobilized fiber column hemoperfusion.

Tomoyuki Kakugawa1, Hiroshi Mukae, Masataka Saito, Koji Ishii, Hiroshi Ishimoto, Noriho Sakamoto, Takahiro Takazono, Yuichi Fukuda, Nobuharu Ooe, Shigeru Kohno.   

Abstract

Amyopathic dermatomyositis (ADM) is a clinical subtype of dermatomyositis, characterized by the absence of motor weakness and the presence of normal muscle enzyme levels. ADM is sometimes accompanied by interstitial pneumonia that shows a rapid progressive course associated with a poor prognosis. We describe a 70-year-old man who presented rapidly progressive interstitial pneumonia associated with clinically ADM (C-ADM); he was successfully treated with polymyxin B-immobilized fiber column (PMX) hemoperfusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18421199     DOI: 10.2169/internalmedicine.47.0639

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  7 in total

1.  Rapid progressive interstitial lung disease as initial manifestation of primary Sjögren's syndrome: a case report.

Authors:  Yihua Lin; Qun Yi; Deyun Cheng
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review.

Authors:  Roberta Vilela Lopes Koyama; Tiago Kiyoshi Kitabayashi Braga; George Alberto da Silva Dias; Satomi Fujihara; Hellen Thais Fuzii; Gilberto Toshimitsu Yoshikawa
Journal:  Clin Rheumatol       Date:  2017-05-09       Impact factor: 2.980

3.  Gene expression analysis for pneumonia caused by Gram-positive bacterial infection.

Authors:  Rufu Jia; Jingyan Yang; Ying Cui; Dongjie Guo; Tiejun Li
Journal:  Exp Ther Med       Date:  2018-02-28       Impact factor: 2.447

Review 4.  Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies.

Authors:  Hidenaga Kawasumi; Takahisa Gono; Yasushi Kawaguchi; Hisashi Yamanaka
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-07-23

5.  Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias.

Authors:  Hiroko Okabayashi; Hidenori Ichiyasu; Sayuri Hirooka; Kimitaka Akaike; Keisuke Kojima; Takayuki Jodai; Yasumiko Sakamoto; Hideharu Ideguchi; Shohei Hamada; Chieko Yoshida; Susumu Hirosako; Shinichiro Okamoto; Hirotsugu Kohrogi
Journal:  BMC Pulm Med       Date:  2017-10-24       Impact factor: 3.317

6.  A Case of Polymyxin b-Immobilized Fiber Column Treatment for Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic Dermatomyositis.

Authors:  Oh Sasaki; Makoto Dohi; Hiroaki Harada; Mitsuru Imamura; Yumi Tsuchida; Kensuke Yamaguchi; Toshihiko Komai; Kazuhiko Yamamoto
Journal:  Case Rep Med       Date:  2013-07-28

7.  Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a/glucocorticosteroid combination therapy: a case control study [corrected].

Authors:  Kentaro Isoda; Tohru Takeuchi; Takuya Kotani; Kenichiro Hata; Takeshi Shoda; Takaaki Ishida; Shuzo Yoshida; Yuko Kimura; Shigeki Makino; Toshiaki Hanafusa
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.